Pharma

Your Article Summary

See Latest Articles

Explaining Innovation
PharmExec, 10/16/09

As Novartis CEO Dan Vasella notes in this month's cover story, pharma has more invested in public policy than any other industry. Not only are companies increasingly dependent on government as a payer for medicines, vaccines, and diagnostics, the cost to invent and commercialize these technologies has grown to the point where even the biggest players have to share the burden.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Ultrasound, nuc med on the upswing
Canadian Healthcare Technology, 10/16/09

See All of Financial Reports